Skip to main content
Updated:
Original:

Phase III COVID-19 vaccine trial halted after 'potentially unexplained illness'

Dr. Michael Osterholm said he'd be surprised if the illness was caused by the potential vaccine.
Author:

A promising COVID-19 vaccine trial has been paused after a patient involved in the study fell ill. Biopharmaceutical company AstraZeneca announced Tuesday that a "standard review" led to the discovery of a "potentially unexplained illness." 

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials," the statement said

AstraZeneca's Phase III trial involves 30,000 people in the United States, including Minnesota recipients through a partnership with HealthPartners Institute. The patient whose possible side effect that triggered the pause is from the United Kingdom. 

The third phase of the vaccine trial launched in early September, with the 30,000 adult patients receiving the potential vaccine or a placebo. The goal of the trial is to assess efficacy and safety of the drug while monitoring systemic and immune reactions. 

"The trial did exactly what it's supposed to do. If we see a potential health issue in one of the recipients, then we have to go ahead and determine if that's associated with the vaccine or if it's just a chance occurrence," said Dr. Michael Osterholm, infectious disease expert at the University of Minnesota, in a Wednesday appearance on WCCO Radio

Follow Bring Me The News on YouTube

Osterholm said the patient in the trial developed inflammation of the spinal cord, though Osterholm added that he "would be surprised if this is associated with the vaccine."

How long the trial will be paused is unclear. 

"We will be guided by this committee as to when the trials could restart, so that we can continue our work at the earliest opportunity to provide this vaccine broadly, equitably and at no profit during this pandemic," said Pascal Soriot, CEO of AstraZeneca. 

According to the Centers for Disease Control and Prevention, vaccine trials that pass Phase III can enter a fourth phase that features ongoing studies after the vaccine is approved and licensed. 

Next Up

Target store

Target unveils deals for 2-day 'Cyber Monday' event

The promotion kicks off Sunday, November 28.

Screen Shot 2021-11-27 at 9.59.30 AM

Edina police warn of recent burglary trend targeting garages and vehicles

The Edina Police Department is increasing patrols in affected neighborhoods in response to the trend.

Screen Shot 2021-11-27 at 9.03.06 AM

Charges: Man shot Uber Eats driver making a delivery in Cottage Grove

Otis Donnell Shipp was charged with second-degree attempted murder after turning himself in on Wednesday.

Screen Shot 2021-11-27 at 7.36.14 AM

Waterfront hotel in Duluth sustains damage in kitchen fire

Authorities estimate the damage at around $75,000.

Screen Shot 2021-11-27 at 7.15.18 AM

Large groups of thieves target 2 Twin Cities Best Buys on Black Friday

It bears similarities to the flash-mob style thefts seen recently in California.

Karl-Anthony Towns

Timberwolves' winning streak snapped at five games

The Wolves' bid for their longest winning streak since 2014 came up short.

Screen Shot 2020-08-14 at 6.45.53 PM

Teen arrested over fatal shooting of 5-year-old boy in Brooklyn Park

Police say the teen was filming a social media video while handling a gun.

Joe Biden

President Biden coming to Minnesota to promote Bipartisan Infrastructure Law

Tuesday's trip follows passage of the $1.2 trillion Bipartisan Infrastructure Deal.

Kirill Kaprizov

Kaprizov gets into the holiday spirit to rout Jets

Kirill Kaprizov's four points led the Wild to a 7-1 victory.

Kirk Cousins

Coller: Cure to Vikings' disrupted season lies in an explosive passing game

The Vikings go to San Francisco knowing that a win would be a huge boost to their playoff hopes.

Related

hockey

How hockey rinks may make it easier for COVID-19 to spread

Dr. Michael Osterholm reckons the cool and warm air in a rink can trap the virus.

Screen Shot 2020-05-27 at 1.47.56 PM

COVID-19 fall peak? Osterholm not expecting a massive 2nd wave

The fall peak has long been dubbed a "worst-case scenario" by Dr. Osterholm.

coronavirus, coronavirus test, covid-19

Studies look at potential scenarios for COVID-19 in Minnesota

Osterholm said the coronavirus "is going to touch every family in Minnesota."

coronavirus, covid-19

HealthPartners to join Oxford University COVID-19 vaccine trial

The Minnesota health system will enroll 1,500 people in the trial.

coronavirus, Iowa

Osterholm: Walz's restrictions could slow COVID-19 'maybe a little bit'

Osterholm believes much stricter mandates are needed to slow the pandemic.

dr. michael osterholm

Relief fund will support families of healthcare workers who died of COVID-19

Dr. Michael Osterholm has partnered with the St. Paul and Minnesota Foundation to launch the Frontline Families Fund.

Screen Shot 2020-05-27 at 1.47.56 PM

Osterholm reiterates COVID-19 going dormant could be bad signal

The infectious disease specialist has said this a few times now.